Lincoln Pharmaceuticals Ltd Half Yearly Results

Gross Sales

308.5

288.94

291.61

246.23

264.08

Excise Duty

0

0

0

0

0

Net Sales

308.5

288.94

291.61

246.23

264.08

Other Operating Income

0

0

0

0

0

Other Income

20.39

18.04

16.39

10.26

12.22

Total Income

328.88

306.98

307.99

256.48

276.3

Total Expenditure

257.38

240.9

239.74

202.84

218.27

PBIDT

71.5

66.08

68.25

53.65

58.03

Interest

0.79

0.65

0.81

1.48

0.55

PBDT

70.71

65.43

67.44

52.17

57.48

Depreciation

6.45

5.5

5.13

4.68

4.49

Minority Interest Before NP

0

0

0

0

0

Tax

10.63

11.32

14.12

11.87

14.12

Deferred Tax

3.63

1.97

1.53

1.45

0.14

Reported Profit After Tax

50

46.64

46.67

34.17

38.72

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

50

46.64

46.67

34.17

38.72

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

50

46.64

46.67

34.17

38.72

EPS (Unit Curr.)

24.96

23.29

23.3

17.06

19.33

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

20.03

20.03

20.03

20.03

20.03

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

23.17

22.86

23.4

21.78

21.97

PBDTM(%)

-

-

-

-

-

PATM(%)

16.2

16.14

16

13.87

14.66